Assessment of hyperkalaemia

Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med. 2000;18:721-729. Abstract

Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592. Abstract

Sica DA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich). 2006;8:67-73. Abstract

1. Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med. 2000;18:721-729. Abstract

2. Chan R, Sealey JE, Michelis MF, et al. Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism. J Lab Clin Med. 1998;132:229-235. Abstract

3. Tamarisa KP, Aaronson KD, Koelling TM. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J. 2004;148:971-978. Abstract

4. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993;44:643-653. Abstract

5. Velazquez H, Perazella MA, Wright FS, et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993;119:296-301. Abstract

6. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med. 1989;87:260-263. Abstract

7. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592. Abstract

8. Bakris GL, Siomos M, Richardson D, et al. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney Int. 2000;58:2084-2092.Full text  Abstract

9. Venzin RM, Cohen CD, Maggiorini M, et al. Aliskiren-associated acute renal failure with hyperkalemia. Clin Nephrol. 2009;98:326-328. Abstract

10. Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;71:575-586. Abstract

11. Pei Y, Richardson R, Greenwood C, et al. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients. Am J Kidney Dis. 1993;22:314-319. Abstract

12. Bushinsky DA, Gennari FJ. Life-threatening hyperkalemia induced by arginine. Ann Intern Med. 1978;89:632-634. Abstract

13. Seto A, Murakami M, Fukuyama H, et al. Ventricular tachycardia caused by hyperkalemia after administration of hypertonic mannitol. Anesthesiology. 2000;93:1359-1361. Abstract

14. Gennari FJ. Hypokalemia. N Engl J Med. 1998;339:451-458. Abstract

15. Sica DA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich). 2006;8:67-73. Abstract

16. Borron SW, Bismuth C, Muszynski J. Advances in the management of digoxin toxicity in the older patient. Drugs Aging. 1997;10:18-33. Abstract

17. Gronert GA. Cardiac arrest after succinylcholine: Mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology. 2001;94:523-529. Abstract

18. Ochoa-Gomez J, Villar-Arias A, Aresti I, et al. A case of severe hyperkalaemia and compartment syndrome due to rhabdomyolysis after drugs abuse. Resuscitation. 2002;54:103-105. Abstract

19. Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med. 1997;103:363-367. Abstract

20. Colussi G, Cipriani D. Pseudohyperkalemia in extreme leukocytosis. Am J Nephrol. 1995;15:450-452. Abstract

21. Graber M, Subramani K, Corish D, et al. Thrombocytosis elevates serum potassium. Am J Kidney Dis. 1988;12:116-120. Abstract

22. Saperstein DS. Muscle channelopathies. Semin Neurol. 2008;28:260-269. Abstract

23. Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.Full text  Abstract

24. Deakin c, Soar J, Davies R. Resuscitation Council UK. Special circumstances guidelines. May 2021 [internet publication].Full text

25. Mahoney BA, Smith WA, Lo DS, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003235.Full text  Abstract

26. National Institute for Health and Care Excellence. Patiromer for treating hyperkalaemia. Feb 2020 [internet publication].Full text

27. National Institute for Health and Care Excellence. Sodium zirconium cyclosilicate for treating hyperkalaemia. Jan 2022 [internet publication].Full text

28. Cheng CJ, Chiu JS, Huang WH, et al. Acute hyperkalemic paralysis in a uremic patient. J Nephrol. 2005;18:630-633. Abstract

29. Viera AJ, Wouk N. Potassium disorders: hypokalemia and hyperkalemia. Am Fam Physician. 2015 Sep 15;92(6):487-95.Full text  Abstract

30. The Renal Association (UK). Treatment of acute hyperkalaemia in adults. 2020 [internet publication].Full text

31. Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19:424-426.Full text  Abstract

32. Wasserman K, Stringer WW, Casaburi R, et al. Mechanism of the exercise hyperkalemia: an alternate hypothesis. J Appl Physiol 1997;83:631-643.Full text  Abstract